CONTACT US   |  (864) 397-5101

The Business Narrative: Science of Success

Courtesy of Greenville Business Magazine

SCbio has reiterated its support of the South Carolina Department of Commerce in recognizing the life sciences industry as a key business sector for economic growth in the Palmetto State.

Through data-driven research, S.C. Commerce has identified the life sciences as one of the long-term areas of focus to enhance economic prosperity.

“The work of SC Commerce makes it clear that when investments are made in South Carolina’s life sciences industry, they will pay off for our residents and economy,” SCbio President and CEO James Chappell said in January.

He added, “The life sciences industry makes South Carolina competitive – it is creating high-wage jobs, developing breakthrough treatments and technologies, and attracting top talent with its acclaimed academic and research institutions.”

“South Carolina is advancing the future as the new home of American innovation,” said Secretary Harry M. Lightsey III. “Driven to create long-term opportunities for the people who call our state home, S.C. Commerce is actively diversifying its industry portfolio by targeting sectors such as life sciences. Our message to life sciences companies is that South Carolina is the place to be from Launch to Legacy!”

The comments were echoed Feb. 7, 2024, at the Hyatt Regency Greenville as several hundred industry leaders, biotech and pharma executives, medical device and medtech innovators, digital health experts, educators and life sciences supporters gathered for the 2024 SCbio Annual Conference.

Robert Coughlin, managing director of JLL and former CEO of MassBio, recounted his son’s struggle with cystic fibrosis, and how a Vertex Pharmaceuticals drug saved his son’s life.

Sarah Kleinpeter. vice president/Alzheimer’s Disease for Novo Nordisk, detailed how dramatic progress is being made and why there is now real hope to prevent and even reverse Alzheimer’s Disease and cognitive decline.

Gov. Henry McMaster, who attended the conference, has made life sciences a top state priority and said officials will work to grow and expand the industry in the Palmetto State.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.